Nyrada

Nyrada Inc. (ASX:NYR)

Nyrada is a preclinical stage, drug discovery, and development company specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases. The Company has two main programs, in cholesterol lowering and brain injury, each targeting market sectors of significant size and considerable unmet clinical need.